Nicolas Girard, MD, PhD

Nicolas Girard, MD, PhD, is head of the medical oncology department at Institut Curie in France.

Articles by Nicolas Girard, MD, PhD

Screenshot of an interview with Nicolas Girard, MD, PhD

SubQ Amivantamab Q4W Maintains Efficacy, Improves Convenience: Nicolas Girard, MD, PhD

ByLaura Joszt, MA,Nicolas Girard, MD, PhD

September 13th 2025

The subcutaneous dose had comparable efficacy to intravenous dosing while enhancing patient convenience in non–small cell lung cancer, explains Nicolas Girard, MD, PhD.

Nicolas Girard, MD, PhD

Articles by Nicolas Girard, MD, PhD

SubQ Amivantamab Q4W Maintains Efficacy, Improves Convenience: Nicolas Girard, MD, PhD

Latest Updated Articles

Trending on AJMC

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD

New French Psoriasis Guidelines Add Biologics, Comorbidity Guidance to Algorithm